Company AnalysisAnalysis as of 17 May 2026

AI-generated · cited to primary sources · not investment advice · How we research

Ugro Capital

BSE:511742
NSE:UGROCAP
Our Conviction
/100
Verdict locked
Mgmt
Business
Growth
Risk
Scenarios

Our verdict on Ugro Capital isn’t the consensus take — see where we landed, and the one risk the bull case glosses over.

See the verdict — free →
01 · Management Credibility

Does management do what it says?

ExceededGross Net NPA and Stage 3 Assets
100/100

The Emerging Market Loan segment is performing significantly better than the steady-state target, with a GNPA of only 1.0% as of Dec'25. (2 exceeded across 2 tracked commitments)

As a steady state, the business is expected to deliver 18% yield, 4% of GNPA and 1.5% of credit cost, contributing to a 40 to 50 basis points return on asset improvement over the next 6 quarters.

Ugro Capital · Concall Transcript · Nov 2025 · p.4
MetOther Findings
91/100

The company added INR 4,387 Cr to its AUM year-on-year, growing from INR 11,067 Cr in Dec'24 to INR 15,454 Cr in Dec'25, significantly exceeding the INR 3,000 Cr annual target. (2 exceeded, 3 met across 5 tracked commitments)

Promoter and Management to potentially own approx. 8.5 Mn shares on a fully diluted basis; vesting conditions are tenure linked over period of next 3 years, thereby aligning management’s goals towards company’s performance and ultimately shareholder returns

Ugro Capital · Investor PPT · Feb 2026 · p.15

See the full cited Management analysis of Ugro Capital

Sign up free →
02 · Business Model

How durable is the business?

Capital Adequacy Ratio CRAR
83/100

Capital adequacy has strengthened to 22.4% following successful rights and preferential issues, providing a larger buffer for growth and the Profectus Capital acquisition. (5 expanding)

CAR improved to 21.2% (vs 20.8% in Dec-25), supporting the Feb-26 commitment of no incremental equity raise over the next three years.

Ugro Capital · Investor PPT · Apr 2026 · p.4
Net Interest Margin by Segment
83/100

Net total income grew significantly by 31% year-on-year, reaching Rs. 216.5 crores, driven by a 31% increase in Assets Under Management (AUM). (5 expanding across 1 engine)

Interest Income 415.2... Total Income 631.7

Ugro Capital · Investor PPT · Apr 2026 · p.15

See the full cited Business Model analysis of Ugro Capital

Sign up free →
03 · Future Growth

Where does growth come from?

Niche Segment Underwriting Edge
73/100

The company is successfully shifting its AUM mix toward high-yield focus verticals. Emerging Market and Embedded Finance now constitute 31% of AUM, up from 25% in Q1'FY25. (5 accelerating across 5 signals)

Shift portfolio to high-yield focus verticals... 85% of AUM by FY29 (currently 38%)

Ugro Capital · Investor PPT · Apr 2026 · p.5
RBI Digital Lending Guidelines Reshaping Distribution
72/100

The company is deepening its play in the $20 billion small retail credit gap through the MyShubhLife (MSL) platform, which is scaling rapidly with a steady monthly run rate. (2 accelerating across 2 signals)

INR 2,280 Cr AUM across ~250k active customers - 6x growth in 15 months

Ugro Capital · Investor PPT · Apr 2026 · p.12

See the full cited Future Growth analysis of Ugro Capital

Sign up free →
04 · Risk

What could break the thesis?

Gross Net NPA and Stage 3 Assets
74/100

The risk is EMERGING/INTENSIFYING. Management explicitly called out stress in the unsecured (Business Loan) portfolio, which has a high GNPA of 4.6%. (5 intensifying, 1 high-severity)

GNPA (%) Mar-25 0.2% ... Mar-26 1.7% GNPA uptick to 1.7% is within underwritten expectations

Ugro Capital · Investor PPT · Apr 2026 · p.12
Other Findings
72/100

The strategic realignment is in full effect, with the company exiting intermediated, yield-dilutive segments to focus on Emerging Market business. This transition is expected to impact near-term growth. (1 stable, 2 high-severity)

AUM is broadly flat quarter-on-quarter. That is intentional. The non-focus intermediated book is running down as planned... Third run down Prime Intermediated portfolio at 15% to 20% annually.

Ugro Capital · Concall Transcript · Apr 2026 · p.4

See the full cited Risk analysis of Ugro Capital

Sign up free →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.